Lu Turkovic

Zagreb, Croatia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

CYP3A4-Mediated Metabolism and Drug-Drug Interaction Potential of Abemaciclib and Letrozole In Vitro.

CYP3A4-Mediated Metabolism and Drug-Drug Interaction Potential of Abemaciclib and Letrozole In Vitro.

Journal: Chemistry & biodiversity

Published: July 15, 2025

An LC-MS/MS-based approach for monitoring monoaminergic status in lizard brains: method development and real-samples application.

An LC-MS/MS-based approach for monitoring monoaminergic status in lizard brains: method development and real-samples application.

Journal: Journal of comparative physiology. A, Neuroethology, sensory, neural, and behavioral physiology

Published: April 17, 2025

Three sample preparation methods for clinical determination of CDK4/6 inhibitors with endocrine therapy in breast cancer patient plasma using LC-MS: Cross-validation (red), ecological (green) and economical (blue) assessment.

Three sample preparation methods for clinical determination of CDK4/6 inhibitors with endocrine therapy in breast cancer patient plasma using LC-MS: Cross-validation (red), ecological (green) and economical (blue) assessment.

Journal: Journal of pharmaceutical and biomedical analysis

Published: September 29, 2024

Development, cross-validation and greenness assessment of capillary electrophoresis method for determination of ALP in pharmaceutical dosage forms - an alternative to liquid chromatography.

Development, cross-validation and greenness assessment of capillary electrophoresis method for determination of ALP in pharmaceutical dosage forms - an alternative to liquid chromatography.

Journal: RSC advances

Published: August 06, 2024

Exploring adherence in patients with advanced breast cancer: focus on CDK4/6 inhibitors.

Exploring adherence in patients with advanced breast cancer: focus on CDK4/6 inhibitors.

Journal: Acta pharmaceutica (Zagreb, Croatia)

Published: November 30, 2023

Dispersive liquid-liquid microextraction followed by sweeping micellar electrokinetic chromatography-tandem mass spectrometry for determination of six breast cancer drugs in human plasma.

Dispersive liquid-liquid microextraction followed by sweeping micellar electrokinetic chromatography-tandem mass spectrometry for determination of six breast cancer drugs in human plasma.

Journal: Journal of chromatography. A

Published: September 28, 2023

Optimisation of Solid-Phase Extraction and LC-MS/MS Analysis of Six Breast Cancer Drugs in Patient Plasma Samples.

Optimisation of Solid-Phase Extraction and LC-MS/MS Analysis of Six Breast Cancer Drugs in Patient Plasma Samples.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: September 18, 2023

Optimisation of dispersive liquid-liquid microextraction for plasma sample preparation in bioanalysis of CDK4/6 inhibitors in therapeutic combinations for breast cancer treatment.

Optimisation of dispersive liquid-liquid microextraction for plasma sample preparation in bioanalysis of CDK4/6 inhibitors in therapeutic combinations for breast cancer treatment.

Journal: Heliyon

Published: July 25, 2023

Rapid Capillary Electrophoresis Method for Simultaneous Determination of Abemaciclib, Ribociclib, and Palbociclib in Pharmaceutical Dosage Forms: A Green Approach.

Rapid Capillary Electrophoresis Method for Simultaneous Determination of Abemaciclib, Ribociclib, and Palbociclib in Pharmaceutical Dosage Forms: A Green Approach.

Journal: Molecules (Basel, Switzerland)

Published: October 07, 2022

Development and Validation of a Novel LC-MS/MS Method for the Simultaneous Determination of Abemaciclib, Palbociclib, Ribociclib, Anastrozole, Letrozole, and Fulvestrant in Plasma Samples: A Prerequisite for Personalized Breast Cancer Treatment.

Development and Validation of a Novel LC-MS/MS Method for the Simultaneous Determination of Abemaciclib, Palbociclib, Ribociclib, Anastrozole, Letrozole, and Fulvestrant in Plasma Samples: A Prerequisite for Personalized Breast Cancer Treatment.

Journal: Pharmaceuticals (Basel, Switzerland)

Published: April 05, 2022

Showing 1-10 of 10

Last Updated: 09/26/2026